ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0729 • ACR Convergence 2020

    Morbidity of JIA-associated Uveitis: Half of Patients Despite Systemic Treatment Still Show Ocular Damage During a Long-term Follow-up

    Francesca Minoia1, Luca Marelli2, Gisella Beatrice Beretta3, Micol Romano4, Elisabetta Miserocchi4, Chiara Mapelli3, Antonella Petaccia3, Stefano Lanni3, Irene Pontikaki4, Giovanni Filocamo3 and Rolando Cimaz5, 1Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 2San Giuseppe Hospital, IRCCS Multimedica, Milan, Italy, Milan, Italy, 3Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 4ASST Gaetano Pini-CTO Institute, Milan, Italy, Milan, Italy, 5ASST Gaetano Pini-CTO Institute and Università degli Studi di Milano, Milan, Italy, Milan, Italy

    Background/Purpose: Uveitis is the most common extra-articular complication of juvenile Idiopathic arthritis (JIA). Due to its typical indolent and chronic course, children with this condition…
  • Abstract Number: 0730 • ACR Convergence 2020

    To Taper or Not to Taper in Juvenile Idiopathic Arthritis: Is There a Risk of Development of Uveitis Flares?

    Maria Teran1, Alina Lucica Boteanu2, Carlos Guillen1, Cristina Pijoan1, Jose Quinones1, Veronica Garcia3, Ivan Del Bosque-Granero3, Laura Calvo-Sanz4 and Mónica Vázquez4, 1Hospital Ramon y Cajal, Madrid, Madrid, Spain, 2PRINTO, Istituto Giannina Gaslini, Genova, Italy, 3Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain, 4Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain

    Background/Purpose: To determine the association between the occurrence of uveitis flares in patients with Juvenile Idiopathic Arthritis (JIA) and the de-intensification of immunosuppressive treatment.Methods: We…
  • Abstract Number: 0731 • ACR Convergence 2020

    Comparing S100 Proteins and Cytokine Levels in Tears Based on Uveitis Activity Laterality in Children with JIA-associated Uveitis and Non-JIA-U

    Jackeline Rodriguez-Smith1, Virginia Miraldi Utz2, Amy Cassedy1, Sherry Thornton1, Grant Schulert3, Alyssa Sproles4, Najima Mwase1, Theresa Hennard1, Mekibib Altaye2, Alexei Grom1 and Sheila Angeles-Han1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnati, 3PRCSG, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital, Cincinnati

    Background/Purpose: The pathogenesis of pediatric uveitis remains unclear. Studies of biomarkers using aqueous humor (AqH) identified S100 proteins, cytokines, and chemokines as potential biomarkers of…
  • Abstract Number: 0732 • ACR Convergence 2020

    Changing Evidence over Time: Updated Meta-analysis Regarding Anti-TNF Efficacy in Childhood Chronic Uveitis

    Ilaria Maccora1, Eleonora Fusco2, Edoardo Marrani3, AV Ramanan4 and Gabriele Simonini5, 1Paediatric Rheumatology Unit, Anna Meyer Children's University Hospital, School of Human Health Science, Florence, Italy, Florence, Italy, 2Rheumatology Unit, Anna Meyer Children's Hospital, School of Human Health Science, University of Florence, Florence, Italy, 3University of Florence, Firenze, Italy, 4Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, United Kingdom, 5Rheumatology Unit, Meyer Children's University Hospital, Florence; NEUROFARBA Department, University of Florence, Italy, Florence, Italy

    Background/Purpose: To summarize evidence regarding efficacy of anti-tumour necrosis factor-α (anti-TNFα) in childhood autoimmune chronic uveitis (cACU), refractory to common disease modifying antirheumatic drugs (DMARDs).Methods:…
  • Abstract Number: 0733 • ACR Convergence 2020

    Practice Patterns for Tapering Medications in the Treatment of JIA-associated Uveitis

    Ivan Foeldvari1, Jens Klotsche2, Sheila Angeles-Han3, Jordi Anton4, Gabriele Simonini5, Nadine Groesch2 and Jean Baer6, 1Head of the Hamburg Centre for Pediatric and Adolescence Rheumatology, Budapest, Hungary, 2German Rheumatism Research Center, Berlin, Germany, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Sant Joan de Déu Hospital, Madrid, Spain, 5Anna Meyer Children's Hospital, Firenze, Italy, 6Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany

    Background/Purpose: Juvenile idiopathic arthritis associated uveitis (JIAU) is the most common extra-articular manifestation of JIA, and occurs in approximately 10% of affected children.  Although there…
  • Abstract Number: 0734 • ACR Convergence 2020

    Differences and Similarities Between down Syndrome-associated Arthritis and Juvenile Idiopathic Arthritis in the New Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry

    Jordan Jones1, Chelsey Smith2, Daniel J Lovell3 and Mara Becker4, 1Children's Mercy Kansas City, Kansas City, MO, 2Children's Mercy Kansas City, Holden, MO, 3PRCSG, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 4Duke University School of Medicine, Durham, NC

    Background/Purpose: Down syndrome-associated arthritis (DA) is under-recognized with delay in diagnosis (1). The majority of those with DA present with polyarticular, rheumatoid factor (RF) and…
  • Abstract Number: 0735 • ACR Convergence 2020

    Paediatric Sarcoidosis: Phenotype of a Retrospective Cohort of Biopsy-proven Patients

    Kerstin Nott1, Veronica Nott2 and Sandrine Compeyrot-Lacassagne1, 1Great Ormond Street Hospital for Children, London, United Kingdom, 2Imperial College, ANDOVER, United Kingdom

    Background/Purpose: Paediatric sarcoidosis is a multisystemic inflammatory condition characterised by the formation of non-caseating granulomata that may lead to end-organ damage. Diagnosis is challenging as…
  • Abstract Number: 0736 • ACR Convergence 2020

    Identification of Salient Resilience Domains Among Adolescents with Chronic Musculoskeletal Pain and Their Parents

    Lauren Pianucci1, Maitry Sonagra2, Daneka Stryker3 and Sabrina Gmuca4, 1Arcadia University, Philadelphia, 2Children's Hospital of Philadelphia, Cherry Hill, NJ, 3Drexel University College of Medicine, Philadelphia, PA, 4Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Adolescents with chronic musculoskeletal pain (CMP) and their parents have been found to have low to moderate levels of resilience and resilience levels are…
  • Abstract Number: 0737 • ACR Convergence 2020

    “It’ll Go Away. There’s Nothing Wrong with you:” the Experience of Pain-Related Stigma Among Adolescents with Pain Amplification Syndrome

    Emily Wakefield1, William Zempsky1, Rebecca Puhl2 and Mark Litt3, 1Connecticut Children's/University of Connecticut School of Medicine, Hartford, CT, 2Rudd Center for Food Policy & Obesity/University of Connecticut, Hartford, CT, 3University of Connecticut School of Medicine, Farmington, CT

    Background/Purpose: Chronic pain in adolescence is a complex and significant medical condition, with a reported prevalence of 11-38%.1 Pain amplification syndrome (PAS), which includes fibromyalgia,…
  • Abstract Number: 0738 • ACR Convergence 2020

    Systemic Administration of Novel Hydroxyl Dendrimers to Target Inflammation in Arthritic Tissues

    Jeffrey Cleland1, Rishi Sharma2, Minghao Sun3, Santiago Appiani La Rosa3 and Rangaramanujam M. Kannan4, 1Ashvattha Therapeutics, Inc, Redwood City, CA, 2Ashvattha Therapeutics, Baltimore, MD, 3Ashvattha Therapeutics, Inc, Baltimore, MD, 4Johns Hopkins School of Medicine, Baltimore, MD

    Background/Purpose: Chronic inflammation observed in arthritis and other autoimmune disorders is mediated primarily by pro-inflammatory reactive macrophages.  Systemic administration of anti-inflammatory agents does not selectively…
  • Abstract Number: 0739 • ACR Convergence 2020

    Toll-like Receptor Inhibitor Peptide Improves the Clinical, Immunologic, and Pathologic Manifestations of Systemic Lupus Erythematosus

    Chang-Hee Suh1, Wook-Young Baek1, Ji-Won Kim1, Yang-Seon Choi2, Sung-Min Lee1, In-Ok Son1, Ki-Woong Jeon1 and Sangdun Choi2, 1Ajou University School of Medicine, Suwon, Republic of Korea, 2Ajou University, Suwon, Republic of Korea

    Background/Purpose: Toll-like receptors (TLRs) are a type of protein that plays a major role in the innate immune system. In recent years, several studies have…
  • Abstract Number: 0740 • ACR Convergence 2020

    Card9 Promotes Th17-mediated Arthritis and Spondylitis via Control of Acute Pathogenic Neutrophil Responses in SKG Mice

    Holly Rosenzweig1, Emily Vance1, Ellen Lee1 and Ruth Napier1, 1Oregon Health & Science University and VA Portland Health Care System, Portland, OR

    Background/Purpose: Caspase recruitment domain-containing protein 9 (CARD9) is an intracellular signal transduction molecule that mediates antimicrobial responses following activation of C-type lectin receptors (ie. Dectin-1) by…
  • Abstract Number: 0741 • ACR Convergence 2020

    Constitutive Inhibitor Kappa B (IκB) Kinase 2 (IKK2) Activation Induces an Inflammatory State in Fibroblast-Like Synoviocytes

    Sergio Ramirez-Perez1, Umesh Gangishetti1, Kyle Jones1 and Pallavi Bhattaram2, 1Department of Orthopaedics, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA, 2EMORY UNIVERSITY, Atlanta, GA

    Background/Purpose: Fibroblast-like synoviocytes (FLS) are key players involved in the production of inflammatory mediators that trigger joint tissue damage in inflammatory arthritis (IA). The most…
  • Abstract Number: 0742 • ACR Convergence 2020

    Effect of IA OnabotulinumtoxinA and Vanilloids on Substance P and Neurokinin 1 Receptor Expression in the Dorsal Root Ganglia of Mice with Monoarthritis

    Hollis Krug1, Nicole Blanshan2, Christopher Dorman2 and Sandra Frizelle2, 1Minneapolis VAHCS and University of Minnesota Medical School, Minneapolis, MN, 2Minneapolis VAHCS, Minneapolis

    Background/Purpose: Neurotoxins are increasingly being proposed as analgesics for arthritis pain. Phase II and III clinical trials have shown efficacy but with potential toxicities such…
  • Abstract Number: 0743 • ACR Convergence 2020

    Higher Baseline Fine-Specificity ACPAs Predict Greater Treatment Response with Abatacept + MTX versus MTX Monotherapy in Seropositive RA: A Post Hoc Analysis

    William Robinson1, Chun Wu2, Sarah Hu2, Sean Connolly2 and Sumanta Mukherjee2, 1Stanford University School of Medicine, Stanford, CT, 2Bristol-Myers Squibb Company, Princeton, NJ

    Background/Purpose: ACPAs are sensitive, highly specific markers of RA. Current tests cannot differentiate ACPA+ RA subtypes. Fine-specificity ACPAs (FS) can distinguish between ACPA+ RA subtypes…
  • « Previous Page
  • 1
  • …
  • 883
  • 884
  • 885
  • 886
  • 887
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology